The use of transdermal scopolamine to solve methodological issues raised by gender differences in susceptibility to simulator sickness
| Autor: | Charles Paillard, Jocelyn Faubert, Guillaume Giraudet, Romain Chaumillon, Jean-François Bouchard, Delphine Bernardin, Thomas Romeas |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
medicine.medical_specialty
Engineering Transportation Placebo Session (web analytics) Motion (physics) 03 medical and health sciences 0302 clinical medicine Physical medicine and rehabilitation Between-group design medicine Scopolamine 0501 psychology and cognitive sciences 050107 human factors Applied Psychology Civil and Structural Engineering business.industry 05 social sciences Driving simulator Safety policy Automotive Engineering Simulator sickness business Social psychology 030217 neurology & neurosurgery medicine.drug |
| Zdroj: | Transportation Research Part F: Traffic Psychology and Behaviour. 47:42-58 |
| ISSN: | 1369-8478 |
| Popis: | While car driving simulators are an essential research tool for assessing drivers’ behavior under safe and controlled conditions, gender differences in susceptibility to simulator sickness is a major drawback for the interpretation of the outcomes. The present study assessed the efficacy of a technological (Experiment 1; the use of motion-based driving simulator) and a pharmacological (Experiment 2; the use of transdermal scopolamine) solution to solve the methodological issues raised by gender differences in susceptibility to simulator sickness. In experiment 1, twenty-four women and twenty-four men performed two driving sessions lasting 16 min within a high-fidelity motion-based driving simulator. In experiment 2, eight women and eight men were tested in the same simulator but received, in a counterbalanced between subjects design, either a placebo or a scopolamine patch 12 h before the experimentation. In both experiments, simulator sickness questionnaire scores were computed before the first driving session and after the first and the second driving sessions. The results showed that only the pharmacological solution was efficient for solving these methodological issues. Indeed, whereas women experienced greater simulator sickness than men under placebo influence (p 0.05). As a whole, this demonstration paves the way toward better-controlled experiments. Moreover, beyond their implications in many research fields, the results from car driving simulator studies are of use to road safety policy makers. Thus, this approach allowing cancellation of gender differences in susceptibility to simulator sickness is of critical importance at a society level. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect